is glp-1 a biologic Discovery of GLP-1–Based Drugs for the Treatment of Obesity Glucagon-like peptide-1 receptor: mechanisms and

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the g-protein-coupled receptor ffar2

This was found not to be sex-dependent, as the rescue was observed in both the female and male mice

Despite its benefits, continued investigation is necessary to establish optimal dosage, long-term effects, and application protocols, ensuring both safety and efficacy in clinical and therapeutic settings

It is well known that metformin primarily inhibits hepatic gluconeogenesis and improves insulin action on muscle and adipose tissue to lower high blood glucose 45,46

Severe peripheral joint laxity is a distinctive clinical feature of Spondylodysplastic-Ehlers-Danlos syndrome (EDS)-B4GALT7 and Spondylodysplastic-EDS-B3GALT6

doi: 10.3390/nu11112579 64 ChenSWeiWChenMQinXQiuLZhangLet al